Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis - ATIS-NVAF study

ational Hospital Organization Osaka National Hospital0 个研究点目标入组 400 人开始时间: 2017年2月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients with a history of myocardial infarction or acute coronary syndrome within the past 12 months 2. Patients who underwent PCI with drug-eluting stents within the past 12 months or PCI with bare-metal stents within the past 3 months 3. Patients who underwent carotid artery stent placement, intracranial stent placement, or lower extremity stent placement within the past 3 months 4. History of symptomatic intracranial hemorrhage or gastrointestinal bleeding within the past 6 months 5. Hemorrhagic diathesis or blood coagulation disorders 6. Platelet counts <100,000 /mm3 at enrollment. 7. Severe anemia (hemoglobin <7 g/dL) 8. Severe renal failure (creatinine clearance =<15 mL/min) or who are undergoing chronic hemodialysis. 9. Severe liver dysfunction (Grade B or C of the Child-Pugh classification) 10. Patients with severe disability requires constant nursing care, bedridden (modified Rankin Scale score =5) 11. Pregnant or possibly pregnant women 12. Active cancer 13. Expectation of survival less than 2 years 14. Anticoagulant or antiplatelet is scheduled to be discontinued for more than 4 weeks during the follow-up period 15. Planned revascularization procedure during the follow-up period 16. Patients who are enrolled in other trials 17. Patients judged as inappropriate for this study by investigators

发起方

ational Hospital Organization Osaka National Hospital